A diagnostic dilemma following risk-reducing surgery for BRCA1 mutation - A case report of primary papillary serous carcinoma presenting as sigmoid cancer

World Journal of Surgical Oncology

Volumn 5, Issue , 2007, Pages

  Chand, Manish ^a   Moore, Patrick J ^a   Clarke, Andrew D ^a   Nash, Guy F ^a   Hickisk, Tamas ^a  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; ARTICLE; BACKACHE; BONE SCINTISCANNING; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CASE REPORT; CLINICAL EXAMINATION; COLON BIOPSY; COLON CANCER; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE SURVEILLANCE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; LAPAROTOMY; MASTECTOMY; OVARY CANCER; PATIENT CARE; PERITONEUM CANCER; PROPHYLAXIS; RECTUM HEMORRHAGE; RISK REDUCTION; SALPINGOOOPHORECTOMY; SPINE METASTASIS; TUMOR VOLUME; ADENOCARCINOMA; BREAST TUMOR; COLON RESECTION; COLON TUMOR; CYSTADENOCARCINOMA; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; METASTASIS; METHODOLOGY; MUTATION; OVARIECTOMY; OVARY TUMOR; PATHOLOGY; PERITONEUM TUMOR; PRIMARY PREVENTION; RISK ASSESSMENT; SECOND CANCER; TIME; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; BREAST NEOPLASMS; COLECTOMY; CYSTADENOCARCINOMA, SEROUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASTECTOMY; MUTATION; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; OVARIECTOMY; PERITONEAL NEOPLASMS; PRIMARY PREVENTION; RISK ASSESSMENT; SIGMOID NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 36148942532     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-5-102     Document Type: Article

References (20)

1. Struewing JP Hartge P Wacholder S Baker SM Berlin M McAdams M Timmerman MM Brody LC Tucker MA The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews N Engl J Med 1997, 336:1401-1408 10.1056/NEJM199705153362001 9145676
2. Ford D Easton DF Stratton M Narod S Goldgar D Devilee P Bishop DT Weber B Lenoir G Chang-Claude J Sobol H Teare MD Struewing J Arason A Scherneck S Peto J Rebbeck TR Tonin P Neuhausen S Barkardottir R Eyfjord J Lynch H Ponder BA Gayther SA Zelada-Hedman Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families Am J Hum Genet 1998, 62:676-689 1376944 9497246 10.1086/301749
3. Satagopan JM Offit K Foulkes W Robson ME Wacholder S Eng CM Karp SE Begg CB The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations Cancer Epidemiol Biomarkers Prev 2001, 10:467-473 11352856
4. Altaras MM Aviram R Cohen I Cordoba M Weiss E Beyth Y Primary peritoneal papillary serous adenocarcinoma: Clinical and management aspects Gynaecol Oncol 1991, 40:230-236 10.1016/0090-8258(90)90283-Q
5. Piura B Rabinovich A Yanai-Inbar I Three primary malignancies related to BRCA mutation successively occurring in a BRCA1 185delAG mutation carrier Eur J Obstet Gynaecol Reprod Biol 2001, 97:241-242 10.1016/ S0301-2115(00)00521-2
6. Levine DA Argenta PA Yee CJ Marshall DS Olvera N Bogomolniy F Rahaman JA Robson ME Offit K Barakat RR Soslow RA Boyd J Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations J Clin Oncol 2003, 21:4222-4227 10.1200/JCO.2003.04.131 14615451
7. Anonymous Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group Br J Cancer 2000, 83:1301-310 10.1054/bjoc.2000.1407 11044354
8. Whittemore AS Gong G John EM McGuire V Li FP Ostrow KL Dicioccio R Felberg A West DW Prevalence of BRCA1 mutations carriers among non-Hispanic Whites Cancer Epidemiol Biomarkers Prev 2004, 13:2078-2083 15598764
9. Liede A Karlan BY Baldwin RL Platt LD Kuperstein G Narod SA Cancer incidence in a population of Jewish women at risk of ovarian cancer J Clin Oncol 2002, 20:1570-577 10.1200/JCO.20.6.1570 11896106
10. Finch A Beiner M Lubinski J Lynch HT Moller P Rosen B Murphy J Ghadirian P Freidman E Foulkes WD Kim-Sing C Wagner T Tung N Couch F Stoppa-Lyoneet D Ainsworth P Daly M Pasini B Gershoni-Baruch R Eng C Olopade OI McLennan J Karlan B Weitzel J Sun P Narod SA Salpingo-oophorectomy and the risk of ovarian, Fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation JAMA 2006, 296:185-192 10.1001/jama.296.2.185 16835424
11. Tobacman JK Greene MH Tucker MA Costa J Kase R Fraumeni JF Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian cancer-prone families Lancet 1982, 2:795-797 10.1016/ S0140-6736(82)92681-2 6126666
12. Kannerstein M Churg J McCaughey WT Hill DP Papillary tumour of the peritoneum in women: Mesothelioma or papillary carcinoma Am J Obstet Gynecol 1977, 127:306-314 835626
13. Lauchlan SC The second mullerian system Obstet Gynecol Surv 1972, 27:133-146 10.1097/00006254-197203000-00001 4614139
14. Stafford-Johnson DB Bree RL Francis IR Korobkin M CT appearance of primary papillary serous carcinoma of the peritoneum AJR Am J Roentgenol 1998, 171:687-689 9725296
15. Thompson D Easton DF Breast Cancer Linkage Consortium Cancer incidence in BRCA1 mutation carriers J Natl Cancer Inst 2002, 94:1358-1365 12237281
16. Breast Cancer Linkage Consortium Cancer risks in BRCA2 mutation carriers J Natl Cancer Inst 1999, 91:1310-1316 10.1093/jnci/91.15.1310 10433620
17. Casey MJ Bewtra C Peritoneal carcinoma in women with genetic susceptibility: Implications for Jewish populations Fam Cancer 2004, 3:265-281 10.1007/s10689-004-9554-y 15516851
18. Kauff ND Satagopan JM Robson ME Scheuer L Hensley M Hudis CA Ellis NA Boyd J Borgen PI Barakat RR Norton L Castiel M Nafa K Offit K Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 2002, 346:1609-1615 10.1056/NEJMoa020119 12023992
19. Piver MS Jishi MF Tsukada Y Nava G Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer: A report of the Gilda Radner Familial Ovarian Cancer Registry Cancer 1993, 71:2751-2755 10.1002/ 1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J 8467455
20. Rebbeck TR Lynch HT Neuhausen SL Narod SA Van't Veer L Garber JE Evans G Isaacs C Daly MB Matloff E Olopade OI Weber BL Prevention and Observation of Surgical End Points Study Group. Prophylactic oophorectomy in carriers of BRCA1 and BRCA2 mutations N Engl J Med 2002, 346:1616-1622 10.1056/NEJMoa012158 12023993